Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination of **Lactated Ringer's injection** and **oxacillin** used for intravenous administration, primarily to deliver fluid and electrolytes while obtaining antimicrobial effects against susceptible organisms, mainly penicillinase-resistant Staphylococcus species. **Lactated Ringer's injection** is a balanced electrolyte solution providing sodium, potassium, calcium, chloride, and lactate, commonly used as an intravenous fluid and diluent. **Oxacillin** is a beta-lactam antibiotic of the penicillinase-resistant class, effective against penicillinase-producing staphylococci. The combination is generally prepared for co-infusion or Y-site administration in clinical settings and is intended for settings where both rehydration and anti-staphylococcal therapy are needed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lactated ringers + oxacillin.